Middle East and Africa Pharma Sector Forecast to 2012

RNCOS has recently added a new Market Research Report titled, "Middle East & Africa Parma Sector Forecast to 2012" to its report gallery. Middle East and Africa pharmaceutical industry entered a new era with the development of infrastructure systems and rapidly changing rules. The industry is blessed with a number of advantages such as high incidence of disease, large population base and many more, reflecting the outlook for growth in the coming years.With these supportive factors are the pharmaceutical industry in the MEA region is expected to surpass the pharmaceutical industry in other regions in the near future.

According to our new analytical research study "Middle East & Africa Parma Sector Forecast to 2012", is the pharmaceutical market in the region expected to grow to a CAGR of around 11% in 2010-2012. Currently, the market is characterized by major changes in regulatory policies in each country. Anticipating future growth, many private key players are investing heavily in the industry to get a chunk of the pie.

Our report found that countries like South Africa, Saudi Arabia and Israel currently dominate the pharmaceutical industry throughout the region. These countries are better off than others in terms of infrastructure and regulatory environment. We also found that MEA pharmaceutical industry is based on imports, with most of the medicines and therapies are procured from overseas and generic hold a majority. The governments of respective countries trying to increase their domestic production by investing heavily in industry. Overall growth in the industry is expected to strengthen in the near future.

Our report also contains extensive information on the Middle East and Africa pharmaceutical market, with detailed description of the nationwide market. It also highlights a number of emerging trends in the market as generic health insurance market, etc. The research study gives detailed statistical and analytical review of healthcare demographics, key drivers and restraints. It contains extensive information together with rational analysis that will help customers to develop market strategies and assess opportunity areas in the Middle East and Africa pharmaceutical market.